Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients.
Christianne Tolêdo de Souza LealLuciano José Megale CostaJuliana PereiraFernando Barroso DuarteRaphael Barros TavaresAngelo AtallaBruna Sousa SabioniAbrahão Elias Hallack NetoPublished in: Bone marrow transplantation (2021)